Significance of IGFBP-4 in the development of fetal growth restriction

Keyphrases

• Insulin-like Growth Factor Binding Protein (IGFBP) 100%
• Fetal Growth Restriction 100%
• Pregnancy-associated Plasma protein-A (PAPP-A) 50%
• Early Pregnancy 30%
• Circulating Levels 20%
• Insulin-like Growth factor-1 20%
• Decidual Cells 20%
• Extravillous Trophoblast Cells 20%
• IGF-I Bioactivity 20%
• IGF2 20%
• Immunohistochemistry 10%
• Western Blot 10%
• Clinical Application 10%
• Odds Ratio 10%
• Serum Levels 10%
• High-level Expression 10%
• Dysregulation 10%
• Human Data 10%
• Protease 10%
• Nested Case-control Study 10%
• Possible Sources 10%
• Normal Weight 10%
• Villi 10%
• Birth Cohort 10%
• Perinatal Mortality 10%
• Late Pregnancy 10%
• Early Biomarker 10%
• Non-pregnant Women 10%
• Syncytiotrophoblast 10%
• Placental Development 10%
• Maternal-fetal Interface 10%
• Maternal Serum 10%
• Ottawa 10%
• Early Gestation 10%
• Placental Growth 10%
• Healthy Pregnancy 10%
• 95% Confidence Interval 10%
• Maternal Circulation 10%
• Perinatal Morbidity 10%

Biochemistry, Genetics and Molecular Biology

• Binding Protein 100%
• Fetus Growth 100%
• Pregnancy-Associated Plasma Protein A 50%
• First Trimester Pregnancy 30%
• Trophoblast 20%
• Placenta Development 20%
• Animal Experiment 10%
• Blood Level 10%
• Case-Control Study 10%
• Western Blot 10%
• Growth, Development and Aging 10%
• Protease 10%
• Third Trimester Pregnancy 10%
• Syncytiotrophoblast 10%
• Perinatal Mortality 10%
• Perinatal Morbidity 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Binding Protein 100%
• Pregnancy Associated Plasma Protein A 50%
• Bioavailability 20%
• Western Blot 10%
• Biological Marker 10%
• Case-Control Study 10%
• Proteinase 10%
• Perinatal Mortality 10%
• Perinatal Morbidity 10%